Naon hartosna "Hapus"?
Sato teu mawa mutasi. Éta moal ngembangkeun panyakit sarta moal lulus eta dina.
Globoid Cell Leukodystrophy (GLD-T) is a genetic disorder affecting terrier breeds, leading to severe neurological degeneration. A DNA test for GLD-T can help identify carriers and affected dogs, ensuring responsible breeding practices. By understanding your terrier's genetic status, you can make informed decisions that promote healthier litters and reduce the risk of this debilitating condition. Early detection through GLD-T testing also aids in managing symptoms and improving the quality of life for affected dogs. Discover how this simple test can contribute to the long-term health of your terrier. Invest in a DNA test today to safeguard your furry companion's future!
Krabbe Disease
Globoid Cell Leukodystrophy in Terriers (GLD-T) is a genetic disorder that affects the nervous system of dogs, particularly in breeds like the West Highland White Terrier. This condition results from a mutation in the GALC gene, leading to the accumulation of toxic substances in the brain. DNA testing can identify carriers of the mutation, enabling breeders to make informed decisions and reduce the incidence of GLD-T. Early diagnosis through genetic testing can also help manage symptoms and improve the quality of life for affected dogs. Responsible breeding practices are essential to ensure the health and well-being of future generations.
Tés DNA ieu kalebet mimitian ti pak kami Basic — sarta ogé mangrupa bagian tina bungkusan Basic, Standard, Advanced, Complete.
Témbongkeun Pek Tés DNA →Globoid Cell Leukodystrophy (GLD) is a severe neurological condition that affects the central nervous system of dogs. It is characterized by the accumulation of certain lipids in the brain, leading to the degeneration of white matter and resulting in various neurological impairments. This condition is particularly notable in terrier breeds, where it manifests as a hereditary disorder.
GLD is caused by a mutation in the gene responsible for producing the enzyme galactocerebrosidase (GALC). This enzyme is critical for the breakdown of specific lipids, and its deficiency leads to toxic accumulation in the brain, ultimately resulting in the death of oligodendrocytes, the cells responsible for myelination. The inherited nature of this condition means that a DNA test can be utilized to identify carriers and affected individuals.
The symptoms of GLD typically begin to manifest in young dogs, often before they reach six months of age. Common clinical signs include loss of coordination, tremors, seizures, and behavioral changes such as increased irritability or anxiety. As the disease progresses, affected dogs may experience severe mobility issues, vision problems, and difficulties in swallowing, leading to further complications and a decline in quality of life.
DNA testing for GLD-T is crucial for breeders and dog owners who wish to make informed decisions about breeding practices. By identifying carriers of the GLD mutation, breeders can take steps to avoid pairing affected dogs, thereby reducing the incidence of this debilitating condition in future generations. Furthermore, early diagnosis through DNA testing can help owners manage the care of affected dogs more effectively, allowing for timely interventions and supportive therapies.
While there is currently no cure for GLD, management strategies focus on improving the quality of life for affected dogs. Supportive care may include physical therapy, dietary adjustments, and medications to alleviate symptoms such as seizures. Additionally, a strong support system from veterinary professionals and pet owners is essential to ensure that affected dogs receive appropriate care and attention throughout their lives.
Globoid Cell Leukodystrophy is a serious genetic condition that poses significant challenges for affected dogs and their owners. DNA testing plays a vital role in understanding and managing this condition, providing valuable information for breeding practices and helping to identify affected individuals early on. As research continues, awareness and education about GLD will be key in promoting responsible breeding and improving the lives of those impacted by this disorder.
Sato teu mawa mutasi. Éta moal ngembangkeun panyakit sarta moal lulus eta dina.
Henteu. Sato umumna séhat tapi tiasa ngirimkeun mutasi ka na turunan.
Ieu mawa dua salinan mutated. tanda klinis diperkirakeun gumantung kana kasakit. Sakuduna teu jadi jawa.
Sababaraha panyakit aya hubungan séks, ku kituna ekspresina béda-béda gumantung kana kelamin sato.
This DNA test detects the mutation associated with Globoid Cell Leukodystrophy In Terrier (GLD) in order to identify clear, carrier, or at-risk animals.
Uji DNA ngabantosan urang sunda ngarencanakeun kawin anu langkung aman sareng ngirangan résiko ngirimkeun mutasi ka turunan.
Modeu warisan anu dilaporkeun pikeun tés ieu nyaéta Autosomal Recessive.
This test analyses the mutation GALC c.473A>C.
Teu kudu. Interprétasi gumantung kana pola warisan sareng genotip anu dihasilkeun.
Victoria T, Rafi M A, Wenger D A. Cloning of the canine GALC cDNA and identification of the mutation causing globoid cell leukodystrophy in West Highland White and Cairn terriers. Genomics. 1996 May 1;33(3):457-62. doi: 10.1006/geno.1996.0220.
Privasi anjeun, pilihan anjeun
Kami nganggo cookies penting pikeun ngajalankeun website. Cookies opsional (sapertos panyadia eusi anu dipasang) ditumpurkeun sacara standar sareng ngan diaktipkeun upami anjeun satuju. Anjeun tiasa ngarobih pilihan anjeun iraha waé nganggo tombol "Cookies".
Diperlukeun pikeun fitur inti jeung kaamanan. Sok diaktipkeun.
Ningkatkeun fitur sapertos nyimpen preferensi atanapi embeds non-iklan.
Ngabantosan urang ngartos pamakean situs. Ditumpurkeun sacara standar.
Iklan / tracking sakuliah situs (sababaraha video / peta embeds). Ditumpurkeun sacara standar.